Literature DB >> 26010146

Sequence analysis of the HBV S protein in Chinese patients with coexisting HBsAg and anti-HBs antibodies.

Feng Ding1, Hong-Gang Yu1,2, Yan-Xia Li1, Ning Cui1, Jin-Fen Dai1, Jie-Ping Yu1.   

Abstract

The coexistence of hepatitis B surface antigen (HBsAg) and antibodies to HBsAg (anti-HBs) in patients with hepatitis B virus (HBV) infection has been discovered and explained for several decades, but debate still exists. This study was to explore the relationship between this special serological pattern and mutations in S gene region. Fifteen patients with coexisting HBsAg and anti-HBs were selected as the experimental group, and 27 patients with HBsAg positive only were selected as the control group. The S gene region was amplified and sequenced. No significant differences were observed between the two groups with regard to age, gender, alanine aminotransferase level, HBsAg titer, genotype, and HBV DNA level. The patients from the two groups were infected with HBV of the genotype B and C. Compared with the control group, the experimental group showed a higher variability in amino acid within the N-terminal region and the MHR, especially the "a" determinant. The most frequent change in patients from the experimental group was located at positions s126. The coexistence of HBsAg and anti-HBs might be associated with the increased amino acid mutations in the "a" determinant. Further studies should be performed to determine the clinical implication of this serological pattern, including the binding of anti-HBs to HBsAg, escape from immune system, and efficacy of antiviral therapy.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  S gene; antibodies to HBsAg; hepatitis B surface antigen; variability

Mesh:

Substances:

Year:  2015        PMID: 26010146     DOI: 10.1002/jmv.24273

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  Identified OAS3 gene variants associated with coexistence of HBsAg and anti-HBs in chronic HBV infection.

Authors:  S Wang; J Wang; M-J Fan; T-Y Li; H Pan; X Wang; H-K Liu; Q-F Lin; J-G Zhang; L-P Guan; D V Zhernakova; S J O'Brien; Z-R Feng; L Chang; E-H Dai; J-H Lu; H-L Xi; Z Zeng; Y-Y Yu; B-B Wang
Journal:  J Viral Hepat       Date:  2018-05-29       Impact factor: 3.728

2.  Clinical and Virological Characteristics of Chronic Hepatitis B Patients with Coexistence of HBsAg and Anti-HBs.

Authors:  Yong Liu; Le Zhang; Jin-Yong Zhou; Jinshun Pan; Wei Hu; Yi-Hua Zhou
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

3.  Evolution of full-length genomes of HBV quasispecies in sera of patients with a coexistence of HBsAg and anti-HBs antibodies.

Authors:  Tai-Cheng Zhou; Xiao Li; Long Li; Xiao-Fei Li; Liang Zhang; Jia Wei
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

4.  Clinical features and viral quasispecies characteristics associated with infection by the hepatitis B virus G145R immune escape mutant.

Authors:  Yuan Xue; Ming-Jie Wang; Zhi-Tao Yang; De-Min Yu; Yue Han; Dao Huang; Dong-Hua Zhang; Xin-Xin Zhang
Journal:  Emerg Microbes Infect       Date:  2017-03-22       Impact factor: 7.163

Review 5.  Paradoxical HBsAg and anti-HBs coexistence among Chronic HBV Infections: Causes and Consequences.

Authors:  Xinyi Jiang; Le Chang; Ying Yan; Lunan Wang
Journal:  Int J Biol Sci       Date:  2021-03-11       Impact factor: 6.580

6.  T-Cell Receptor β Chain and B-Cell Receptor Repertoires in Chronic Hepatitis B Patients with Coexisting HBsAg and Anti-HBs.

Authors:  Qiao Zhan; Le Chang; Jian Wu; Zhiyuan Zhang; Jinghang Xu; Yanyan Yu; Zhenru Feng; Zheng Zeng
Journal:  Pathogens       Date:  2022-06-26

7.  Patients with Coexistence of Circulating Hepatitis B Surface Antigen and Its Antibody May Have a Strong Predisposition to Virus Reactivation During Immunosuppressive Therapy: A Hypothesis.

Authors:  Yu-Lan Chen; Ying-Qian Mo; Dong-Hui Zheng; Jian-Da Ma; Jun Jing; Lie Dai
Journal:  Med Sci Monit       Date:  2017-12-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.